Literature DB >> 29059074

Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing.

Clauden Louis1, Emily Calamaro2, Jeffrey M Vinocur2.   

Abstract

PURPOSE OF REVIEW: The modern field of clinical genetics has advanced beyond the traditional teachings familiar to most practicing cardiologists. Increased understanding of the roles of genetic testing may improve uptake and appropriateness of use. RECENT
FINDINGS: Clinical genetics has become integral to the management of patients with hereditary arrhythmia and cardiomyopathy diagnoses. Depending on the condition, genetic testing may be useful for diagnosis, prognosis, treatment, family screening, and reproductive planning. However, genetic testing is a powerful tool with potential for underuse, overuse, and misuse. In the absence of a substantial body of literature on how these guidelines are applied in clinical practice, we use a case-based approach to highlight key lessons and pitfalls. Importantly, in many scenarios genetic testing has become the standard of care supported by numerous class I recommendations; genetic counselors can improve accessibility to and appropriate use and application of testing.
SUMMARY: Optimal management of hereditary arrhythmias and cardiomyopathies incorporates genetic testing, applied as per consensus guidelines, with involvement of a multidisciplinary team.

Entities:  

Mesh:

Year:  2018        PMID: 29059074     DOI: 10.1097/HCO.0000000000000477

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  2 in total

1.  Molecular Approach of Hereditary Arrhythmias, Long QT Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Hanife Saat; İbrahim Şahin; Haktan Bağış Erdem; Senem Özgür; Semiha Terlemez Tokgöz; Taha Bahsi
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

2.  Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy.

Authors:  Hanne M Boen; Bart L Loeys; Maaike Alaerts; Johan B Saenen; Inge Goovaerts; Lut Van Laer; Anne Vorlat; Tom Vermeulen; Constantijn Franssen; Patrick Pauwels; Inez Rodrigus; Hein Heidbuchel; Emeline M Van Craenenbroeck
Journal:  J Heart Lung Transplant       Date:  2022-04-09       Impact factor: 13.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.